Studies to examine the best tumor reduction rate for predicting the pCR after two cycles docetaxel chemotherapy breast preoperative
Not Applicable
- Conditions
- Invasive breast cancer
- Registration Number
- JPRN-UMIN000015224
- Lead Sponsor
- agasaki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient with suspected infection has a fever or a patient, has been complicated by infection. 2. Patients with drug allergies severe. 3. Renal failure severe, patients with (jaundice) liver failure. 4. Patients with pulmonary fibrosis or interstitial pneumonia evident in chest X-ray. 5. Enhanced MRI of patients contraindicated 6. Patients with hypertension, diabetes uncontrolled.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method